Applies to Medicaid plans.
Not coveredDocument explicitly states 'ZEPBOUND (TIRZEPATIDE) (NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS)'. No weight loss PA criteria are established; coverage is only available for the OSA indication.
Policy note: Explicitly not covered for weight loss as a standalone indication. Header explicitly states 'NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS.'
Policy effective July 1, 2026 · verified June 4, 2026 · source: 20260701 Public Facing GLP-1%20 Ra Gip Combinations PA Final · View policy document (PDF)